Deepcell, a leader in AI-driven single cell analysis, has entered a research collaboration with NVIDIA to advance computer vision solutions in life sciences. Integrating NVIDIA AI into its technology, Deepcell aims to co-develop generative AI and multimodal applications for enhanced cell biology understanding. The collaboration targets accelerated adoption of AI-powered cellular analysis across cancer, stem cell, and cell therapy research. Deepcell’s REM-I platform, set for full commercialization in 2024, combines high-dimensional cell morphology analysis with sorting capabilities, promising groundbreaking insights through the synergy of their expertise with NVIDIA’s resources.
Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced a research collaboration with NVIDIA to accelerate the development and adoption of advanced computer vision solutions in life sciences.
Deepcell will incorporate NVIDIA AI into its single cell analysis technology, working collaboratively with NVIDIA to codevelop new uses for generative AI and multimodal applications in cell biology. The joint collaboration aims to advance understanding of cell morphology, and ultimately accelerate the use of AI-powered cellular analysis in cell biology and translational research across a broad swath of applications including cancer, stem cell, and cell therapy.
Revolutionizing Life Sciences Through Cutting-Edge AI Collaboration
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Deepcell, in partnership with NVIDIA, is poised to revolutionize life sciences by harnessing the power of multimodal generative AI. This collaboration aims to develop innovative algorithms, utilizing NVIDIA’s Clara suite and computing expertise, to enhance cell image analysis. Deepcell’s REM-I platform, set to be fully commercialized in 2024, integrates high-dimensional cell morphology analysis and sorting capabilities, enabling groundbreaking discoveries in cancer biology, developmental biology, stem cell biology, gene therapy, and more. The synergy between Deepcell’s technological strengths and NVIDIA’s resources promises to usher in a new era of insights and advancements in the field.
“Deepcell has catalyzed the field of morpholomics and showcased the benefits of a revolutionary new method for single-cell analysis using brightfield cell imaging and artificial intelligence,” said Mahyar Salek, Ph.D., Cofounder, President, and Chief Technology Officer at
Deepcell. “As we look to the future, we see many possibilities for incorporating multimodal and generative AI into our platform, and leveraging our proprietary database of billions of cell images to train additional AI models. Our relationship with NVIDIA will help us accelerate such enhancements, and bring these advancements to our customers, enabling new discoveries at unprecedented speed.”
Source: Bio Space